Since 1975
  • facebook
  • twitter
  • instagram
  • Home
  • Pfizer applies for COVID-19 vaccine approval in Japan

Pfizer applies for COVID-19 vaccine approval in Japan

The move raises the possibility of vaccination starting as early as March next year. (AFP)
The move raises the possibility of vaccination starting as early as March next year. (AFP)
Short Url:
18 Dec 2020 12:12:33 GMT9
18 Dec 2020 12:12:33 GMT9

TOKYO: The Japanese arm of US pharmaceutical giant Pfizer Inc. said Friday that it has asked Japan’s health ministry to approve its COVID-19 vaccine.

It is the first application in Japan for regulatory approval of a vaccine for the novel coronavirus.

The move raises the possibility of vaccination starting as early as March next year.

The vaccine, jointly developed by Pfizer and Germany’s BioNTech SE, is already being administered in countries such as the United States and Britain after receiving emergency use authorization.

“Once the application arrives, we will make a decision by examining its efficacy and safety,” health minister Norihisa Tamura said at a press conference the same day.

JIJI Press

Most Popular
Recommended

return to top